Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METAREM: Adaptive Master Trial for Advanced Cancers
NCT07431073Phase 2Recruiting
- Sponsor
- Unicancer
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in cancer, sponsored by Unicancer. Primary endpoints: Efficacy of novel treatment strategies at 7 years and Evaluation of patient selection criteria at 7 years. Started Aug 2026; status: recruiting.
02
Conditions
cancer
Beyond the preview
Go deeper on NCT07431073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07431073.